
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
Some rheumatoid arthritis patients experience lung manifestations, such as interstitial lung disease, but how do you identify these patients? Test your knowledge with this quiz.
How common is lung involvement in rheumatoid arthritis?






